Financialsexperimental
Marijuana Co of America, Inc.. Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD (whole amounts) · shares (whole numbers) · per-share amounts in USD
| Income Statement | Q3 FY22 30 Sept 2022 | Q2 FY22 30 Jun 2022 | Q1 FY22 31 Mar 2022 | Q4 FY21 31 Dec 2021 | Q3 FY21 30 Sept 2021 |
|---|---|---|---|---|---|
| Sales | 142,394 | 258,628 | 561,321 | 536,261* | 442,178 |
| Related party Sales | 0* | 0 | |||
| Total Revenues | 142,394 | 258,628 | 561,321 | 536,261* | 442,178 |
| Cost of sales | 58,200 | 38,599 | 510,262 | 466,399* | 378,491 |
| Gross Profit | 84,194 | 220,029 | 51,059 | 69,862* | 63,687 |
| Depreciation and amortization | 51,108 | 51,109 | 51,050 | ||
| Depreciation and amortization | 94,984* | 3,697 | |||
| Selling and marketing | 43,835 | 96,094 | 81,373 | 26,558* | 167,664 |
| Payroll and related | 241,504 | 260,211 | 276,913 | 268,554* | 142,830 |
| Stock-based compensation | 9,000 | 161,000 | 9,000 | 519,652* | 529,393 |
| General and administrative | 631,514 | 574,774 | 468,517 | 642,544* | 639,767 |
| Total operating expenses | 976,961 | 1,103,188 | 886,853 | 1,552,292* | 1,483,352 |
| Net loss from operations | -892,767 | -883,159 | -835,794 | -1,482,430* | -1,419,664 |
| Interest expense, net | -761,060 | -852,319 | -1,246,155 | -1,760,185* | -549,363 |
| Gain (loss) on change in fair value of derivative liabilities | -1,026,929 | 455,531* | 1,177,610 | ||
| Impairment loss on Acquisition | -2,020,982 | ||||
| Realized Gain (loss) on trading securities | 6,086 | ||||
| Gain (loss) on change in fair value of derivative liabilities | 957,862 | ||||
| (Loss) Gain on change in fair value of derivative liabilities | -126,136 | ||||
| Loss on share exchange agreement | -340,984 | ||||
| Gain (loss) on trading securities | 0* | ||||
| Loss on equity investment | -2,009,254 | ||||
| (Loss) Gain on sale of trading securities | 0* | 543,200 | |||
| Loss on settlement of debt | -148,324 | 0* | -187,500 | -153,668* | -88,990 |
| Total other income (expense) | -3,044,774 | -1,915,439 | -2,454,498 | -1,458,322* | -344,927 |
| Net loss before income taxes | -3,937,541 | -2,798,598 | -3,290,292 | -2,940,752* | -1,764,591 |
| NET LOSS | -3,937,541 | -2,798,598 | -3,290,292 | -2,940,752* | -1,764,591 |
| Foreign currency Translation Adjustment | -17,393 | 6,961 | -2,548 | ||
| Loss per common share, basic and diluted | -0 | ||||
| Comprehensive Loss | -3,954,934 | -2,791,637 | -3,292,840 | ||
| Weighted average number of common shares outstanding, basic and diluted (after stock-split) | 5,266,505,915 | ||||
| Loss per common share, basic and diluted | -0 | -0 | -0 | ||
| Weighted average number of common shares outstanding, basic and diluted (after stock-split) | 12,698,727,773 | 10,157,215,172 | 8,162,150,740 |